• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II SHUNT ASSEMBLY, REGULAR, WITH BIOGLIDE; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II SHUNT ASSEMBLY, REGULAR, WITH BIOGLIDE; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 27819
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 01/16/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The returned valve was patent.The valve met the requirements for valve flux, siphon, reflux, preimplantation, and pressure-flow testing.It did not meet the requirements for leak testing.The valve did not meet the requirements for leak testing due to tears/cuts on the casing of the delta chamber.Damage was also observed on the side of the delta chamber.It is unknown how or when this damage occurred.The ifu cautions, ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting or crushing of components.Such damage may lead to loss of shunt integrity¿¿ particulates/debris were also observed in the valve.It is unknown how or when these particulates/debris entered the valve.The ifu cautions, ¿care must be taken to ensure that particulate contaminants are not introduced into shunt components during preimplantation testing or handling.Introduction of contaminants could result in improper performance of the shunt system.Particulate matter that enters the shunt system may result in shunt occlusion¿¿ all valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that during the patency check, the physician found that the delta chamber leaked.The valve was replaced and there was no injury to the patient.
 
Additional Manufacturer Narrative
Patient weight provided.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II SHUNT ASSEMBLY, REGULAR, WITH BIOGLIDE
Common Device Name
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key8167905
Report Number2021898-2018-00564
Device Sequence Number1652894
Product Code JXG
UDI-Device Identifier00643169010499
UDI-Public00643169010499
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K042465
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2019
Device Model Number27819
Device Catalogue Number27819
Device Lot NumberE16472
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/04/2018
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/18/2018
Supplement Date Received by Manufacturer12/26/2018
Initial Report FDA Received Date12/16/2018
Supplement Report FDA Received Date01/07/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age44 YR
Patient Weight70
-
-